A study on the TNF-α system in Caucasian Spanish patients with alcoholic liver disease

Abstract Background Tumor necrosis factor-alpha (TNF-α) is thought to be a critical driving force of inflammatory damage in alcoholic liver disease (ALD). We aimed to establish whether there is a correlation between plasma levels of the soluble TNF-α receptors 1 and 2 (sTNFR1 and sTNFR2) and the severity of liver damage in patients with ALD. We also aimed to elucidate whether functionally active polymorphisms in the promoter region of the TNF-α gene modulate the development of ALD. Design We studied 614 Spaniards. Of these, 278 were alcoholics (103 without liver histologic abnormalities, 89 with non-cirrhotic liver disease and 86 with cirrhosis) and 336 were non-alcoholics (115 healthy controls, 114 with non-alcoholic non-cirrhotic liver disease and 107 with cirrhosis unrelated to alcohol). Plasma levels of sTNFR1 and sTNFR2 were determined by ELISA and results were expressed in ng/mL and subsequently converted in log 10 . TNF-α gene promoter region polymorphisms at the positions −238, −308 and −863 were assessed by restriction fragment length polymorphisms (RFLPs) on white cell DNA. Differences in plasma sTNFR1 and sTNFR2 levels between groups were compared with the one-way and two-factor analysis of variance test, and Student's t -test. Genotype distribution and allele frequencies in the different groups were compared using the χ 2 test or Fisher's exact test. Results sTNFR1 and sTNFR2 plasma levels were significantly higher in patients with cirrhosis than in those with non-cirrhotic liver disease ( p p p  = 0.003 and p TNF-α genotype distribution and allele frequencies of the three loci assessed were similar in the groups studied, hence no particular genotype or haplotype could be linked to ALD. Conclusions The TNF-α system is activated in patients with cirrhosis of the liver irrespective of aetiology. TNF-α polymorphisms at positions −238, −308 and −863 are not linked to ALD.